Pharma Journalist -

Vaxart, Inc. announced an agreement with hVIVO Services Limited, a subsidiary of Open Orphan plc under which hVIVO will conduct a characterization study and, if successful, develop a…
Read More...

Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and clinical development in oncology, announced that the U.S. Food and Drug Administration (FDA)…
Read More...

Twist Bioscience Corporation and Ildong Pharmaceutical announced an agreement under which Ildong will license a suite of Twist VHH antibody libraries to use to discover and develop…
Read More...

Blueprint Medicines Corporation announced strategic financing collaborations with Sixth Street and Royalty Pharma for up to $1.25 billion, bringing significant non-dilutive, low-cost…
Read More...

Oxford Biomedica plc announces that it has signed a new three year Master Services & Development Agreement with AstraZeneca UK Ltd which would facilitate potential future…
Read More...

GSK plc announced it has completed the acquisition of Sierra Oncology, Inc. (Sierra Oncology), a California-based biopharmaceutical company focused on targeted therapies for the…
Read More...

Brii Biosciences Limited announced that it exercised its option to acquire exclusive development and commercialization rights for VIR-3434 in Greater China as part of its broader…
Read More...

Pfizer Inc. announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of PAXLOVID (nirmatrelvir tablets and ritonavir…
Read More...

Agilent Technologies Inc. announced a collaboration agreement with APC Ltd., in which the companies commit to working towards combining their technologies to provide unique workflows to…
Read More...

Pfizer Inc. and BioNTech SE announced a new vaccine supply agreement with the U.S. government to support the continued fight against COVID-19. Under the agreement, the U.S. government…
Read More...